A large body of evidence for G-proteincoupled receptor (GPCR) oligomerization has accumulated over the past 2 decades. The smallest of these oligomers in vivo most likely is a dimer that buries 1000-Å 2 intramolecular surfaces and on stimulation forms a complex with heterotrimeric G protein in 2:1 stoichiometry. However, it is unclear whether each of the monomers adopts the same or a different conformation and function after activation of this dimer. With bovine rhodopsin (Rho) and its cognate bovine G-protein transducin (G t ) as a model system, we used the retinoid chromophores 11-cis-retinal and 9-cis-retinal to monitor each monomer of the dimeric GPCR within a stable complex with nucleotide-free G t . We found that only 50% of Rho* in the Rho*-G t complex is trapped in a Meta II conformation, while 50% evolves toward an opsin conformation and can be regenerated with 9-cisretinal. We also found that all-trans-retinal can regenerate chromophore-depleted Rho 
Insights into the molecular architecture of G-protein-coupled receptors (GPCRs) and their activation mechanisms have been gained steadily over the past 2 decades. These were derived initially from secondary structure predictions of GPCR overall topology (1, 2) , through low-resolution 3-dimensonal structures (3) and then structures of native crystallized rhodopsin (Rho; ref. 4) , photoactivated Rho (Rho*), and ligandfree and chromophore-bound opsin (5) (6) (7) (8) (9) . This steady progress was complemented recently by various constructs in the presence of agonists and antagonists of thermostabilized receptors (10) and the fusion of modified GPCRs and fast folding soluble proteins (11) .
GPCRs form homo-and heterodimeric and oligomeric structures (12) identified by imaging of native membranes (13, 14) . Moreover, obligatory heterodimeric functional expression was documented primarily for family C GPCRs that contain large N-terminal domains (15) . For the largest family A of GPCRs, however, the situation is more complex. Purified family A monomeric receptors can activate G proteins, both alone and when reconstituted into nanodiscs, where they apparently retain a monomeric structure (16, 17) . However, lack of direct organizational proof complicates the interpretation of these last experiments. The nature of their diffusible ligands and rather crude assays employed lacked the sensitivity to distinguish between different oligomeric states, particularly because oligomers could rapidly form and break apart (18) . Nonetheless, transgenic mouse experiments (19, 20) , electron microscopic studies (21, 22) , and some crystallographic structures (7, 23 ) support a vast number of different biochemical assays and spectroscopic approaches (24 -26) indicating that family A GPCRs have an intrinsic propensity to dimerize/oligomerize.
The family A GPCR Rho has been a model for G-protein signaling for decades (27) . This membrane protein has also offered opportunities to advance the structural and functional understanding of GPCR oligomerization. Thus, Rho photoactivated states can be readily monitored spectrophotometrically because inactive Rho with its 11-cis-retinylidene chromophore absorbs around 500 nm, whereas Rho*, the so-called metarhodopsin II (Meta II) formed in the all-transretinylidene configuration, absorbs at ϳ380 nm (28) . After chromophore release from Rho*, the resulting opsin can be recharged physiologically with 11-cisretinal to regenerate light-sensitive Rho (24) , or with the 9-cis-retinal analog to form isorhodopsin (isoRho), which absorbs at 485 nm (29) . The isomeric state of chromophore can also be chemically analyzed after rapid hydrolysis with hydroxylamine in ethanolic solution and separation of the retinal isomers by highperformance liquid chromatography (HPLC). In native membranes, all-trans-retinylidene is hydrolyzed, and all-trans-retinal slowly released from the binding pocket is recycled back to the 11-cis conformation by a series of enzymatic reactions termed the retinoid cycle. Notably, depletion of guanosine triphosphate (GTP) and guanosine diphosphate (GDP) stabilizes the complex between Rho and its cognate G-protein transducin (G t ) for biochemical manipulation (30) . Visualization of Rho*-G t complexes with (unpublished results) and without the succinylated lectin, succinylated concanavalin A (sConA; ref. 21, 31) unequivocally indicates a pentameric assembly of the Rho*-G t complex in which the photoactivated Rho dimer serves as a platform for binding the G t heterotrimer, as predicted previously (32) . The pentameric nature of this Rho*-G t complex reveals that each Rho monomer in the complex must be differently arranged in its interaction with G t . However, it is unclear whether the Rho monomers have separate functions in the pentameric complex. In this study, we demonstrate that photoactivated dimeric Rho is structurally and functionally in an asymmetric state in the Rho*-G t complex.
MATERIALS AND METHODS

Chemicals
Guanosine 5=-3-O-(thio)triphosphate (GTP␥S) and 9-cis-retinal were purchased from Sigma-Aldrich (St. Louis, MO, USA). n-Dodecyl-␤-d-maltoside (DDM) was obtained from Affymetrix (Maumee, OH, USA). Bradford Ultra was purchased from Novexin (Cambridge, UK). 11-cis-retinal was a generous gift from Dr. R. Crouch (Medical University of South Carolina, Charleston, SC, USA). All-trans-retinal was purchased from Toronto Research Chemicals (Toronto, ON, Canada).
Purification of Rho
Bovine rod outer segment (ROS) membranes were prepared from fresh retinas under dim red light, as described previously (33) . These were solubilized in DDM and used for Rho purification by a ZnCl 2 -opsin precipitation method (34) . ZnCl 2 was removed by a 48-h dialysis in the presence of 0.2 mM DDM. Rho concentrations were measured with a UVvisible spectrophotometer (Cary 50; Varian, Palo Alto, CA, USA) and quantified by using the absorption coefficient ε 500nm ϭ 40,600 M Ϫ1 cm Ϫ1 (35) .
Purification of G t
G t was purified after extraction with hypotonic buffer from ROS membranes isolated from 200 dark-adapted bovine retinas as described previously (36) . Briefly, ROS membranes were resuspended in 30 ml of isotonic buffer, composed of 20 mM HEPES (pH 7.5), 5 mM MgCl 2 , 1 mM dithiothreitol (DTT), and 100 mM NaCl, and soluble proteins were removed by gentle homogenization, followed by centrifugation at 25,000 g at 4°C for 15 min. G t was extracted from the pellet by 3 washes with 30 ml of hypotonic buffer, composed of 5 mM HEPES (pH 7.5), 0.1 mM EDTA, and 1 mM DTT; membranes were pelleted after each wash by centrifugation at 25,000 g at 4°C for 30 min. All 3 wash supernatants were combined and centrifuged at 25,000 g for 60 min to remove remaining ROS membrane contaminants. Then 1 M HEPES (pH 7.5) was added to the final supernatant to reach a final concentration of 10 mM, and MgCl 2 was added to achieve a 2 mM final concentration. The resulting sample in this equilibrating buffer was applied at a flow rate of 15 ml/h to a 10-ϫ 100-mm column loaded with 5 ml of preequilibrated pentylagarose resin, and the column was washed with 10 column vol of equilibrating buffer. Bound proteins were eluted with a 50-ml linear gradient of 0 to 0.5 M NaCl in the equilibrating buffer at a flow rate of 15 ml/h, and 1-ml fractions were collected. Fractions containing G t were pooled and concentrated by 30,000 normal molecular weight limit (NMWL) Centricon devices (Millipore, Billerica, MA, USA). G t was purified to homogeneity on a tandem Superdex 200 gel filtration column equilibrated with buffer composed of 10 mM HEPES (pH 7.5), 100 mM NaCl, 2 mM MgCl 2 , and 1 mM DTT at 4°C (flow rate 0.4 ml/min with collection of 0.5 ml fractions). Fractions containing G t were combined and concentrated by 30,000 NMWL Centricon devices (Millipore) to ϳ10 mg protein/ml, as determined by the Bradford assay (37) .
Purification and regeneration of Rho*-G t and Rho* e -G t complexes
The Rho*-G t complex was purified by sConA affinity chromatography, as described previously (21) . Briefly, the sConA affinity resin was prepared by coupling sConA (Vector Laboratories, Burlingame, CA, USA) to CNBr-activated agarose (Santa Cruz Biotechnology, Santa Cruz, CA, USA) at a density of 8 mg sConA/ml of resin. Purified Rho (200 g) was diluted to ϳ0.2 mg/ml and loaded onto the sConA column (400 l) equilibrated with an equilibrating buffer (20 mM BTP, pH 6.9, containing 120 mM NaCl, 1 mM MnCl 2 , 1 mM CaCl 2 , 1 mM MgCl 2 , 1 mM DTT, and 0.5 mM DDM). The resin was washed with 5 column vol of the same buffer and then illuminated for 10 min with a 150-W fiber light (Dolan Jenner Industries, Boxborough, MA, USA) delivered through a 480-to 520-nm bandpass filter. Purified native G t (200 g), diluted to ϳ0.2 mg/ml with this equilibrating buffer, was applied to the column immediately after light exposure. Excess G t was washed out with 10 column vol of the above buffer. To obtain the chromophore-depleted Rho*-G t (Rho* e -G t ) complex, the Rho*-G t complex bound to the column was first washed with 40 mM NH 2 OH in the equilibrating buffer. Excess NH 2 OH was washed out with 10 column vol of the equilibration buffer. Then Rho*-G t or Rho* e -G t complexes were either eluted from the column with the elution buffer (equilibration buffer containing 200 mM ␣-methyl-d-mannoside) or regenerated with a specified retinoid. Alternatively, Rho itself was bound to the sConA affinity resin, and opsin was generated by light illumination (as described above), followed by a prolonged wash (200 column vol) with the equilibrating buffer, and eluted with the elution buffer. Opsin concentration was determined from its absorption at 280 nm using the extinction coefficient ε ϭ 81,200 M Ϫ1 cm Ϫ1 (38) .
Regeneration of Rho*-G t and Rho* e -G t complexes and opsin
To regenerate Rho*-G t , Rho* e -G t or opsin, a 2-fold molar excess of either 9-cis-retinal, 11-cis-retinal, or all-trans-retinal was used (see Results). An ethanolic solution of the selected retinoid diluted with equilibration buffer (final ethanol concentration Ͻ1%) was loaded on a column with specific bound complexes. The column then was closed for 1 h and kept at 4°C in the dark. Excess retinal then was washed out with 10 column vol of equilibrating buffer, and proteins were eluted. Fractions containing either Rho*-G t , Rho* e -G t , or chromophore-regenerated complexes were used for spectral analyses by UV absorption and/or biochemical analysis of retinoid components.
UV-visible spectroscopy
UV-visible absorption spectra of purified Rho*-G t , Rho* e -G t , or complexes regenerated with either all-trans-retinal, 9-cisretinal, or 11-cis-retinal were measured at 20°C with a Cary 50 Varian spectrophotometer. To determine the presence of a Schiff base linkage vs. free retinal in the Rho* e -G t complex regenerated with all-trans-retinal, we acidified the sample with H 2 SO 4 to a final pH of 1.9. Retinylidene-lys 296 has an absorption peak at 440 nm, whereas maximum absorption of free retinal is at 365 nm (39, 40) .
Fluorescence measurements
A 2-fold molar excess of 11-cis-retinal or all-trans-retinal was added to freshly purified Rho* e -G t or opsin (1 M), diluted with buffer composed of 20 mM BTP (pH 6.9), 120 mM NaCl, 1 mM MnCl 2 , 1 mM CaCl 2 , 1 mM MgCl 2 , 1 mM DTT, and 0.5 mM DDM, and then quenching of intrinsic tryptophan fluorescence was measured with a Perkin Elmer L55 Luminescence Spectrophotometer (Perkin Elmer, Wellesley, MA, USA) at 20°C. Emission spectra at 0 and 10 min after chromophore addition were recorded between 310 and 450 nm after excitation at 295 nm with excitation and emission slit bands set at 5 and 10 nm, respectively. For time-resolved measurements, fluorescence emission spectra were recorded at 330 nm under conditions outlined above.
Dissociation of Rho* e -G t or chromophore-regenerated complexes by GTP␥S
Rho* e -G t , Rho* all-trans-RAL -G t , Rho* 9-cis-RAL -G t , or Rho* 11-cis-RAL -G t complexes were all dissociated by adding 200 M GTP␥S while they were still bound to an sConA affinity column.
Retinoid analyses
Rho*-G t , Rho* e -G t , opsin, or chromophore-regenerated complexes (ϳ100 g protein) were denatured for 30 min at room temperature with 50% CH 3 OH in the presence of 40 mM NH 2 OH. The resulting retinal oximes were extracted with 300 l of hexane, and their isomeric composition was determined by normal-phase HPLC with an Ultrasphere-Si, 5 m, 4.5-ϫ 250-mm column (Beckman, San Ramon, CA, USA). Retinoids, eluted isocratically with 10% ethyl acetate in hexane at a flow rate of 1.4 ml/min, were detected by their absorption at 360 nm (41, 42) . Retinoid oximes were quantified based on areas under corresponding chromatography peaks. Amounts of retinals were calculated based on a standard curve presenting the correlation between areas and peaks of synthetic standards for each retinal oxime isomer. NaBH 4 reduction of the Schiff base in Rho* all-trans-RAL -G t or Rho* sConA resin with bound Rho* all-trans-RAL -G t (3 ml) was transferred from the column to a 50-ml tube as a 50% slurry. The secondary amine was produced by reduction of the Schiff base bond in Rho with excess of NaBH 4 by a procedure described previously (43) . Briefly, 6 mg of solid NaBH 4 was added to a tube containing resin with bound regenerated Rho* all-trans-RAL -G t complex and, following 30 min incubation on ice, the resin was loaded into the column again. NaBH 4 was washed out with 5 column vol of the equilibrating buffer, and Rho* all-trans-RAL -G t containing the reduced Schiff base bond was eluted from the resin. Its UV-visible spectrum showed a peak at 330 nm, indicating formation of secondary amine, a product of Schiff base chemical reduction. This protein was concentrated to ϳ3 mg/ml and used for mass spectrometry (MS) analyses.
Alternatively, the control sample of Rho* with trapped endogenous all-trans-retinal was prepared as follows: ROS membranes (200 l with ϳ1 mg/ml Rho) were illuminated for 10 min at room temperature, and the Schiff base bond between isomerized all-trans-retinal and opsin was reduced with NaBH 4 . NaBH 4 (40 mg/ml) was added to the membranes in 5-l aliquots 5 times at 5-min intervals. Excess NaBH 4 was removed by overnight dialysis against fresh H 2 O. Membranes were solubilized with 10 mM DDM and used for MS analyses.
MS identification of a Schiff base linkage in the Rho* e -G t complex regenerated with all-trans-retinal
Rho* all-trans-RAL -G t (or free Rho*; 20 g) was digested overnight with pepsin (10 g; Worthington, Lakewood, NJ, USA) at pH 2.5 and room temperature after the pH had been lowered from 6.9 to 2.5 with 0.1% formic acid in H 2 O. Following this overnight procedure, the pH of the sample was adjusted to 7.4 with 10 l of 0.5 M Tris-HCl (pH 7.4), and peptic fragments were acetylated by adding acetic anhydride (99.5%; Sigma) at a rate of 2.5 l/10 min for 50 min. The resulting sample was used for MS analysis with an LXQ mass spectrometer (Thermo Scientific, Waltham, MA, USA) equipped with an electrospray ionization source that operated in a positive mode with the capillary temperature set to 350°C. The mass spectrometer was coupled to a HP 1100 HPLC system (Agilent Technologies, Santa Clara, CA, USA). Peptide separation was achieved by a 2-pump controlled reverse phase elution setup with an aqueous phase composed of 0.1% formic acid in H 2 O (phase A) and an organic phase composed of 0.1% formic acid in acetonitrile (phase B). The sample (100 l) was loaded onto a Luna 20-ϫ 2.00-mm C18 column (Phenomenex, Torrance, CA, USA) equilibrated with 98% phase A and 2% phase B for 30 min. Peptides were eluted with the following gradients: 0 to 4 min, 98% phase A and 2% phase B; 4 to 38 min, 2% phase A and 98% phase B.
Tandem MS (MS 2 ) and triple MS (MS 3 ) spectra were collected by using collision-induced dissociation with the normalized collision energy set to 35 kV. Spectra were analyzed and interpreted with Xcalibur software (ver. 2.1.0.1139; Thermo Scientific).
Preparation of retinoid-modified peptide standard
The 6-aa acetyl-FAKTSA peptide standard (the same that was identified in both Rho* all-trans-RAL -G t complex and free R*) was custom ordered (EZBbiolab, Westfield, IN, USA) and conjugated with retinal as follows: 1 mg peptide was dissolved in acetonitrile-methanol at a 1:1 ratio, mixed with 1 mg of all-trans-retinal and 1% acetic acid, and incubated 48 h at room temperature to form the Schiff base linkage, following reduction with NaHB 4 . Solid NaHB 4 (ϳ2 mg) was added to the sample, and the mixture was incubated for 30 min on ice. Then 500 l H 2 0 was added to react with excess NaHB 4 . Acetyl-FAK*TSA peptide (wherein K* is the retinoid modified lysine) was extracted with chloroform, dried in a SpeedVac (Thermo Scientific), and dissolved in 1:1 acetonitrile-methanol, and used immediately for MS analysis or stored at Ϫ20°C.
RESULTS
G t prevents all-trans-retinal release from photoactivated Rho
Photoactivation of Rho results in sequential steps of 11-cis-retinylidene chromophore isomerization to alltrans-retinylidene, followed by Schiff base linkage hydrolysis and release of all-trans-retinal (44, 45) . In its transient state, Rho* binds to the heterotrimeric G protein, transducin, promoting dissociation of GDP from G t␣ and formation of the transitory Rho*-G t complex. Although short-lived in nature, this Rho*-G t complex can be trapped as a stable intermediate in the absence of nucleotides. Electron microscopy (EM) and single-particle reconstruction of this Rho*-G t complex recently revealed its pentameric assembly with a Rho to G t stoichiometry of 2:1 (21). This complex exhibits a UV-visible maximum absorption peak at 380 nm and contains only all-trans-retinal bound, indicating that G t stabilizes the activated conformation of Rho and inhibits retinal release from the retinal-binding pocket. However, the chromophoric stoichiometry of this stabilized adduct has not been documented. To determine the effect of G t on retinal release from the chromophore-binding pocket of photoactivated Rho, we prepared sConA resin that bound either the Rho* dimer or the Rho*-G t complex. Extensive washing of resin bound-Rho* with buffer containing DDM resulted in nearly complete depletion of the chromophore ( Fig. 1 ; retinoid analysis plots, left top and bottom panels, also modeled yellow-yellow Rho dimer transitioned to gray-gray Rho dimer, shown on the left). In contrast, chromophore release from the Rho*-G t complex was only partial, with ϳ50% of all-trans-retinal remaining trapped in the chromophore-binding pocket ( Fig. 1 ; retinoid analysis plots, right top panel and bottom left panel, also modeled yellow-yellow Rho dimer coupled to G t transitioned to yellow-gray Rho dimer coupled to G t shown on the right), indicating a protective role of bound G t . To achieve complete chromophore release from the Rho*-G t complex, a wash with NH 2 OH was applied to promote Schiff base hydrolysis. The resulting chromophore-depleted Rho* e -G t complex remained intact ( Fig. 1 ; model of gray-gray Rho coupled to G t ) but sensitive to dissociation by GTP␥S ( Fig. 1 ; SDS-PAGE gels, bottom center, also model of gray-gray Rho coupled to G t transitioned to gray-gray Rho dimer).
Binding of cis-chromophore to the Rho* e -G t complex
To determine whether the chromophore-depleted Rho* e -G t complex could be regenerated with 11-cisretinal to form Rho or with 9-cis-retinal to form isoRho, the specific retinoid was added to Rho* e -G t bound to the sConA resin and excess retinoid was washed out. Formation of Rho or isoRho still coupled to G t was monitored immediately after their elution from the column by either UV-visible absorption spectroscopy or HPLC analyses of retinoids extracted from the regenerated complexes. Regeneration of Rho* e was documented by an increased maximum absorption at 485 or 500 nm after Rho* e -G t ( Fig. 2 ; model of gray-gray Rho dimer coupled to G t ) incubation with 9-cis-retinal or 11-cis-retinal, respectively ( Fig. 2A) . (The peak at ϳ380 nm observed in both samples could result from a deprotonated form of the Schiff base). HPLC retinoid analyses of the complex regenerated with 9-cis-retinal (Rho 9-cis-RAL -G t ) primarily identified 9-cis-retinal (95%) with only a small fraction of all-trans-retinal (5%), indicating that both Rho molecules of the dimer had been regenerated with 9-cis-retinal (Fig. 2B , light blue line; also model of pink-pink Rho dimer coupled to G t ). However, a ϳ1:1 ratio of 11-cis-retinal (44%) and all-transretinal (56%) was identified in the Rho* 11-cis-RAL -G t complex (Fig. 2B, dark blue line) . Therefore, only one Rho of the dimer could be regenerated with 11-cis-retinal, whereas the second Rho monomer promoted the isomerization of the less stable 11-cis-retinal to all-trans-retinal, the conformation present in the active state of Rho ( Fig.  2 ; model of yellow-red Rho dimer coupled to G t ). Both Rho* 11-cis-RAL -G t (Fig. 2C ) and Rho 9-cis-RAL -G t (not shown) remained functionally active after elution from their respective sConA columns, because both were sensitive to dissociation by GTP␥S. After dissociation of the Rho* 11-cis-RAL -G t complex and loss of protection ensured by bound G t , all-trans-retinal was released from the chromophore binding pocket, resulting in the formation of the Rho* e -Rho dimer, where one Rho monomer is in an opsin-like conformation, and the second in a ground, 11-cis-retinal bound state ( Fig. 2 ; model of gray-red Rho dimer).
Quenching of intrinsic tryptophan fluorescence by incorporation of 11-cis-retinal and all-trans-retinal into Rho* e -G t or opsin
Here interactions between retinal and protein were monitored by recording changes in the intrinsic fluo-rescence of tryptophan. Addition of a 2-fold molar excess of either 11-cis-retinal or all-trans-retinal to the sample rapidly generated retinoid uptake signals for the chromophore-depleted samples of opsin ( Fig. 3C,  D ; insets) and Rho* e -G t complex (Fig. 3) , manifested as quenched intrinsic protein fluorescence. These observations indicated formation of a complex between Rho* e in the Rho* e -G t complex and either 11-cis-retinal or all-trans-retinal ( Fig. 3 ; models of yellow-red Rho dimer coupled to G t and yellow-gray Rho dimer coupled to G t , respectively). Remarkably, while the fluorescence of free opsin was quenched by 11-cis-retinal, only a minor change in opsin intrinsic fluorescence was observed after addition of all-trans-retinal ( Fig. 3C, D; insets). These results indicate a structural difference between retinal-free Rho* e in the Rho* e -G t complex and opsin.
Asymmetry of Rho monomers in the Rho*-G t complex
As described above, G t bound to photoactivated Rho inhibited release of all-trans-retinal, trapping ϳ50% of this isomerized endogenous chromophore in its binding pocket. This uneven protection of Rho monomers comprising the dimer demonstrates asymmetric properties of Rho molecules in the Rho*-G t heteropentamer ( Fig. 4 ; model of yellow-gray Rho dimer coupled to G t ). To investigate this phenomenon further, we incubated the Rho*-G t complex with an excess of 9-cis-retinal and monitored product regeneration by UV-visible absorbance spectroscopy and retinoid analyses. The Rho*-G t complex exhibited a UV-visible absorption spectrum with a major peak at ϳ380 nm, whereas peaks at 380 and 485 nm were detected in the sample regenerated with 9-cis-retinal (Fig. 4B) . Though only all-trans-retinal was detected in the Rho*-G t complex ( Fig. 4A ; black spectrum and model of yellow-gray Rho dimer coupled to G t ), a mixture of all-trans-retinal and 9-cis-retinal with a 1:1 stoichiometry was detected in the Rho* 9-cis-RAL -G t complex ( Fig. 4A ; very dark gray spectrum and model of yellow-pink Rho dimer coupled to G t ), indicating that bound G t prevents release of all-trans-retinal from only one Rho molecule, while the second one eventually loses its chromophore and can be loaded with 9-cis-retinal. This result demonstrates functional and structural asymmetry of Rho dimer triggered by G t binding. Regeneration of the Rho*-G t with 9-cis-retinal did not affect the integrity of the complex (Fig. 4C) complex to 200 M GTP␥S promoted release of the endogenous all-trans-retinal originally trapped by G t in the chromophore-binding pocket ( Fig. 4A ; dark gray spectrum and model of gray-pink Rho dimer). A significant reduction of all-trans-retinal but not 9-cis-retinal in the intact Rho* 9-cis-RAL -G t complex was also achieved by treatment with NH 2 OH ( Fig. 4A ; light gray spectrum and model of gray-pink Rho dimer coupled to G t ).
All-trans-retinal forms a Schiff base linkage when added to the Rho*-G t complex
In dark-state Rho, 11-cis-retinal, and, in the Rho-activated state, all-trans-retinal, are covalently attached to Lys 296 in the chromophore-binding pocket. However, other than this main retinal-binding site, secondary binding sites exist on the surface of opsin where retinal can bind noncovalently (46) . As previously reported (47), all-trans-retinal added to detergent-solubilized opsin does not form a Schiff base linkage with Lys 296 but, rather, attaches noncovalently. In the present study, we investigated whether a Schiff base bond is formed between added all-trans-retinal and Lys 296 of chromophore-depleted Rho* e in the Rho* e -G t complex. First, the Schiff base bond in the regenerated Rho* all-trans-RAL -G t complex was stabilized by reduction with NaBH 4 , resulting in creation of a stable secondary amine from n-retinylidene Schiff base exhibiting a UV absorption peak at 330 nm (Fig. 5A) . This sample was acidified and digested with pepsin, and then the products were acetylated and analyzed by MS. This proce- (Fig. 5C ). The same result was obtained with a Rho* sample prepared by illumination of ROS membranes, which, following NaBH 4 -Schiff base reduction, carried endogenous all-trans-retinal (Fig. 5D) . Fragmentation of the m/z 269.3 product revealed its identity as an anhydroretinol carbocation (Fig. 5E ), whereas fragmentation of the second m/z 666.5 product produced a MS 3 spectrum that corresponded to the retinoid-free acetyl-FAK*TSA peptide (Fig. 5F ). To further test this interpretation, we generated a synthetic standard acetyl-FAK*TSA peptide. This synthetic peptide exhibited a MS identical to that of the proposed acetyl-FAK*TSA peptide (Fig. 6A) as identified peptide. The MS 2 of this singly charged ion also yielded 2 major ions, one with m/z 269.3, corresponding to the retinoid, and the other with m/z 666.5, corresponding to the peptide alone (Fig. 6B) . Fragmentation of the m/z 269.3 ion was identical to the same ion in both the acetyl-FAK*TSA peptide standard (Fig. 6C ) and the retinylamine retinoid standard (Fig. 6E, F, respectively) . Fragmentation of m/z 666.5 was identical to the same ion present in the acetyl-FAK*TSA peptide standard (Figs. 5F and 6D,  respectively) . These results clearly demonstrate that G t Figure 2 . Regeneration of the Rho* e -G t complex with either 11-cis-retinal or 9-cis-retinal. Rho* e -G t was prepared by treatment of the Rho*-G t complex with NH 2 OH (modeled as graygray dimer bound to G t ). While still bound to the column, chromophore-depleted Rho* e -G t was regenerated with a 2-fold molar excess of either 11-cis-retinal (shown as a yellow-red dimer bound to G t ) or 9-cis-retinal (shown as pinkpink dimer bound to G t ). Excess retinoid was washed out, and regenerated complexes were eluted and analyzed by UV-visible absorbance measurements and retinoid oxime quantification. A) UV-visible absorption spectra of Rho* e -G t , Rho* 11-cis-RAL -G t and Rho 9-cis-RAL -G t are shown with black, dark blue, and light blue lines, respectively. B) Isocratic analyses of retinoid oximes extracted from Rho* 11-cis-RAL -G t (dark blue line) and Rho 9-cis-RAL -G t (light blue line) complexes. Most of the 9-cis-retinal (95%) and a small fraction of all-trans-retinal (5%) were identified in the Rho 9-cis-RAL -G t complex, whereas a mixture of 11-cis-retinal (44%) and all-trans-retinal (56%) were found in the Rho* 11-cis-RAL -G t complex. C) SDS-PAGE gel of Rho* 11-cis-RAL -G t purified by sConA affinity chromatography (left panel). Asterisk inciates the eluted peak fraction containing both Rho and G t . Functionality of this complex was evidenced by its dissociation with 200 M GTP␥S. Pound signs indicate fractions containing dissociated G t . Asterisk indicates peak fraction eluted from the column containing mostly Rho.
bound to the chromophore-depleted Rho* e dimer stabilizes the active conformation of Rho, allowing access of exogenous all-trans-retinal to the retinal-binding pocket and reformation of a Schiff base linkage with Lys 296 .
DISCUSSION
Convincing evidence indicates that GPCR dimerization and activation are intricately associated. The functional consequences of GPCR dimerization have been revealed by studies showing intercommunication between 2 protomers in these dimers (19, 48 -50) . Whereas such cooperation can be relatively easily proven for heterodimers, it is more challenging for homodimeric GPCRs.
Here we studied the properties of dimeric Rho, a prototypic member of family A GPCRs. In native membranes, Rho exists as densely packed dimers organized in rows (13) . Although the functional relevance of Rho's dimeric nature is highly debated, we have shown by EM and single-particle reconstruction that, in response to light, a Rho dimer is required for binding to a single G protein (21) . Until now it has been unclear whether both Rho monomers within the activated dimer are structurally and functionally equivalent. Therefore, by unequivocally tracing each Rho monomer with an isomeric variant of the chromophore, we probed the symmetry of a Rho dimer within the stable Rho*-G t complex. This strategy indicated that each monomer in the Rho dimer coupled to G t exhibited different conformational properties (Fig. 7) . Only one Rho, most likely the one hosting the C terminus of G t␣ , is stabilized in its active Meta II state with its chromophore, all-trans-retinal, trapped in the retinal-binding pocket. But at the same time, all-trans-retinal is released from the second Rho, which eventually decays to opsin and free retinal ( Fig. 7 ; yellow-gray Rho dimer bound to G t ). Interestingly, this chromophore-free Rho* e molecule can be regenerated with 9-cis-retinal without affecting the integrity and activity of the whole Rho* 9-cis-RAL -G t complex. As evidenced by HPLC retinoid analysis, such a regenerated complex retained both all-trans-retinal and 9-cis-retinal in a 1:1 stoichiometry, demonstrating unambiguously that 2 Rho molecules are bound to 1 G t , which influences their functional and structural distinction ( Fig. 7 ; yellow-pink Rho dimer bound to G t ). Stabilized by G t , a Rho monomer can lose its chromophore only after complex dissociation with GTP␥S, or its hydrolysis can be effected by treatment of the intact complex with the strong nucleophile NH 2 OH, resulting in formation of the chromophore-depleted Rho* e -G t complex ( Fig. 7 ; gray-gray Rho dimer bound to G t ). Such a complex is still active and can be regenerated with different isomeric variants of chromophore. Interestingly, HPLC analysis of retinoids extracted from the Rho* e -G t complex after incubation with 11-cis-retinal resulted in a mixture of 11-cis-retinal and all-trans-retinal in ϳ1:1 ratio, indicating that only one Rho molecule in the dimer was regenerated with 11-cis-retinal, whereas the other was bound to all-trans-retinal ( Fig. 7 ; yellow-red Rho dimer bound to G t ). The only possible explanation of this unexpected discovery is that one of the Rho monomers is stabilized by G t in its active Meta II-like state even after chromophore depletion. Consequently, the rigid constraints of this protein force the isomerization of 11-cis-retinal to its all-trans conformer, because only the latter can fit the chromophore-binding pocket of Meta II-like Rho. This protein-forced retinal isomerization, however, was not observed for the more stable 9-cis-retinal, which regenerated both Rho molecules of the Rho* e -G t complex ( Fig. 7 ; pink-pink Rho dimer bound to G t ).
Another key finding here is that chromophore-depleted Rho* e bound to G t could uptake exogenous all-trans-retinal into its empty retinal-binding pocket and reform a Schiff base linkage between this retinal and its reactive lysine K 296 . But as shown previously (47), all-trans-retinal does not reenter the chromophore-binding pocket of free opsin, presumably because the conformational equilibrium is shifted toward the inactive conformation. Moreover, all-transretinal can enter only one of the two retinal-free Rho* e molecules in the Rho* e -G t complex, implying that, unlike the Rho monomer in the opsin conformation, only the Rho* monomer stabilized by G t in the Meta II-like state can provide access to all-trans-retinal (results not shown; Fig. 7 ; yellow-gray Rho dimer bound to G t ).
Rho's agonist and antagonist ligands are covalently linked to the opsin moiety, thus allowing an excess of free ligand to be washed out (51) . Indeed, the chromophore-opsin interaction gives rise to specific absorption spectra characteristic of both the chromophore and the activated state of the receptor. Thus the switch from agonistic (cis-retinoid) to antagonistic (all-transisomer) retinoid can be readily monitored by UV-visible spectroscopy, whereas the presence of chromophore in the binding site can be followed by fluorescence spectroscopy that reveals the quenching of fluorescence emanating from the specific Trp residues involved in retinoid binding (47, 52) . Moreover, because of the high absorption coefficient of the chromophore, its isomeric nature can be determined by chemical analysis using HPLC and MS even on small sample sizes. Finally, this methodology can be applied to unmodified Rho/ opsin-transducin complexes isolated from native sources, e.g., bovine eyes. All these advantages over other family A GPCR systems enabled us to study the nature of each Rho monomer within G t -bound pentameric complex and the dimeric complex without G t . Figure 4 . Asymmetry of Rho monomers in the Rho*-G t complex. The Rho*-G t complex prepared on an sConA affinity resin (modeled as a yellow-gray dimer bound to G t ) was regenerated with 9-cis-retinal (shown as a yellow-pink dimer bound to G t ), followed by either dissociation with GTP␥S (depicted as a gray-pink dimer) or treatment with NH 2 OH (modeled as a gray-pink dimer bound to G t ). UV-visible absorbance spectra and retinoid composition of those complexes then were analyzed. A) Isocratic analyses of retinoid oximes extracted from Rho*-G t (black line), regenerated with 9-cis-retinal, Rho* 9-cis-RAL -G t (very dark gray line), Rho* 9-cis-RAL -G t treated with either GTP␥S (dark gray line) or with NH 2 OH (light gray line) are shown. Although only all-trans-retinal was detected in the Rho*-G t complex, a mixture of all-trans-retinal and 9-cis-retinal with a 1:1 stoichiometry was found in the Rho* 9-cis-RAL -G t complex. Treatment of Rho* 9-cis-RAL -G t with GTP␥S resulted in significant reduction in all-transretinal, and an even further reduction was obtained after a wash with NH 2 OH. B) UVvisible absorption spectra of Rho*-G t and regenerated Rho* 9-cis-RAL -G t are shown by black and light blue lines, respectively. C) SDS-PAGE gel of Rho* 9-cis-RAL -G t purified by sConA affinity chromatography. Asterisk indicates the peak fraction containing both Rho* and G t .
The results also provide direct evidence for a different conformational arrangement of Rho monomers within the dimer after assembly with G t .
When high-resolution structures of vertebrate (4) and invertebrate (53) Rho molecules and structures of GPCR-interacting proteins, such as G proteins (54), arrestins (55) , and GRKs (56, 57) became available, it transpired that GPCRs, as well as their partner proteins, share striking structural similarity (average root-meansquare deviation Ͻ2 Å). Along with structural information, physiological findings also support the functional hetero-oligomerization of GPCRs. For example, the mGluR family of receptors' activation mechanism involves a change in quaternary structure of two obligatory monomers coupled to each other by a disulfide bridge (58, 59) ; the GABAB receptor functional unit is an obligate heterodimer composed of GABAB1 and GABAB2 subunits (60 -62); and obligate heterooligom- Relative intensity (%) ers of taste receptors exist for sweet and umami responses (63, 64) . These were the first examples that unequivocally established dimerization and its functional importance. Mindful that the function of all GPCRs depends on intermolecular interactions with G proteins, GRKs, and arrestins along with additional evidence that GPCRs have a propensity to form homoand heterooligomers, it seems logical that dimerization is not a unique characteristic of only a few receptors but rather a property of a whole subclass of GPCRs. Modeling studies also indicated that the Rho dimer offers a geometrically compatible platform for the binding of partner proteins, such as G t or arrestin, because each of the latter exhibit a "footprint" larger than that of a Rho monomer (32, 65, 66) . The Rho-G t -induced fit model implies that activation could involve the relaxation of a somewhat more rigid structure constituting the inactive state of the receptor, following a further increase of its rigidity on G t binding (67) . This process occurs differentially within GPCR monomers, as shown in this work; thus, each Rho* provides a different platform for an interaction with G t . This interpretation agrees with the recent structural model for the photoactivated Rho*-G t complex featured in a low-resolution 3-dimensional Relative intensity (%) map obtained by EM-single particle reconstruction (21, 31) . Its molecular envelope accommodated two Rho molecules together with one G t heterotrimer, consistent with a heteropentameric structure of this complex as shown by the present biochemical approach. This evidence sharply contrasts with that derived from crystal structures of an active state complex comprised of agonist-occupied monomeric ␤ 2 -adrenergic receptor-T4L-lyzosome fusion, nucleotide-free G s heterotrimer, and a nanobody, which provides the most unexpected structure, with a major displacement of the entire ␣-helical domain of G ␣ relative to the Ras-like GTPase domain (68) . The latter is a rigid body type of displacement, where one subdomain dives into the lipid bilayer with an averaged angle between subdomains of ϳ130°, whereas the distance between the ␣-helical subdomains of G t and G s was found to be ϳ40 Å (68). Thus, for the two domains to superpose, a full ϳ180°rotation of the G s␣ -␣-helical subdomain alone is required. Therefore, the relevance of this monomeric GPCR structural model to general GPCR physiology, in our view, remains an open question. Together with our EM structural data, the results presented here unambiguously demonstrate that after light activation, a single G t heterotrimer binds to a Rho dimer (21, 31) . In the Rho*-G t complex thus formed, each Rho monomer is structurally different, and only one is stabilized in the active Meta II state by bound G t , while the other evolves into an opsin-like conformation. Although the physiological role of this dimer asymmetry has yet to be clarified, regulation of the clearance of excess all-trans-retinal produced under bright light conditions, where Rho*-Rho* dimer would be at a significantly higher level as compared to Rho-Rho* as a mechanism protecting rod cells, is an intriguing possibility. The concept of Rho dimer asymmetry agrees also with possible cross-communication between GPCR protomers within a dimer. Rho and Rho* share the same recognition mode for G t (69) . Therefore it is possible that precoupled Rho-G t complexes exist in the dark. Taking into account that only one Rho molecule within the dimer can provide binding determinants for G t␣ , a possibility of asymmetric Rho activation arises. In such situations, photoexcitation of chromophore and its isomerization in the Rho monomer that does not physically interact with G t␣ , would induce conformational changes in the precoupled Rho monomer, leading to conformational evolution toward the Meta II Figure 7 . Asymmetry of Rho* dimer within Rho*-G t complex. The Rho*-G t complex is formed by binding of a fully activated Rho dimer to G t . After light illumination, 11-cis-retinal of ground state Rho (shown as red-red dimer) isomerizes to all-trans-retinal (yellow-yellow dimer), allowing binding of the heterologous G t trimer (G t␣ is depicted in salmon, G t␤ in green, and G t␥ in light blue). This binding prevents chromophore release from one Rho in the dimer, introducing dimer asymmetry in the Rho*-G t complex (shown after a wash as a yellow-gray dimer bound to G t ). Release of chromophore from the G t -protected Rho molecule can be promoted by NH 2 OH, resulting in formation of the chromophore-free Rho* e -G t complex (modeled as a gray-gray dimer bound to G t ). This complex then can be either dissociated with GTP␥S (shown as gray-gray dimer) or regenerated. 9-Cis-retinal regenerates both Rho monomers in the dimer (shown as a pink-pink dimer bound to G t ). However, 11-cis-retinal regenerates only one Rho monomer, while the second Rho promotes isomerization of 11-cis-retinal to its all-trans conformer, resulting in formation of an asymmetric dimer (indicated by a yellow-red dimer bound to G t ). Both complexes regenerated with either 9-cisor 11-cis-retinal can be dissociated with GTP␥S (shown as pink-pink or gray-red models, respectively). But regeneration with all-trans-retinal results in its uptake by only one Rho monomer (shown as a yellow-gray dimer bound to G t ), and the second Rho can be regenerated with 9-cis-retinal (shown as yellow-pink dimer bound to G t ). All-trans-retinal can be released from such complexes by either NH 2 OH (modeled as a gray-pink dimer bound to G t ) or GTP␥S (imaged as a gray-pink dimer).
